发明公开
- 专利标题： COMPLEMENT COMPONENT C5 ANTIBODIES
- 专利标题（中）： ANTIKÖRPERDER KOMPLEMENTKOMPONENTE C5
-
申请号： EP15708398.1申请日： 2015-02-19
-
公开(公告)号： EP3107935A2公开(公告)日： 2016-12-28
- 发明人: BACIU, Peter C. , LIANG, Yanbin , GUU, Jason , BERNETT, Matthew , MUCHHAL, Umesh , DESJARLAIS, John
- 申请人： ALLERGAN, INC. , Xencor, Inc.
- 申请人地址： 2525 Dupont Drive Irvine, CA 92612 US
- 专利权人： ALLERGAN, INC.,Xencor, Inc.
- 当前专利权人： ALLERGAN, INC.,Xencor, Inc.
- 当前专利权人地址： 2525 Dupont Drive Irvine, CA 92612 US
- 代理机构： Hoffmann Eitle
- 优先权： US201461768374P 20140220; US201461944943P 20140226
- 国际公布： WO2015127134 20150827
- 主分类号： C07K16/18
- IPC分类号： C07K16/18 ; A61K39/395
摘要：
The present disclosure relates to antibodies and polynucleotides encoding the same, that may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement C5. Specifically, the disclosure is related to C5 antibodies.
公开/授权文献
- EP3107935B1 COMPLEMENT COMPONENT C5 ANTIBODIES 公开/授权日：2020-06-24
信息查询
